|
| Status |
Public on Mar 01, 2015 |
| Title |
MDA-MB-468_siPRKCD_rep3 |
| Sample type |
RNA |
| |
|
| Source name |
MDA-mB-468 cells treated with siPRKCD
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: MDA-mB-468 breast cancer cell line
treatment: siPRKCD
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Qiagen Rneasy
|
| Label |
biotin
|
| Label protocol |
Illumina®Totalprep-96RNA Amplification kit 4397949 RevC, (Modification of Amplification kit v 2.2)
|
| |
|
| Hybridization protocol |
WGGEX_Direct_Hybridization_Assay_EUC_11322187_A
|
| Scan protocol |
Standard Illumina iScan N240 scanning protocol
Scan setting file: Direct Hyb
|
| Description |
Sample name: 468d3.a1.lbe1
|
| Data processing |
The data were normalized using quantile normalization with BASE
|
| |
|
| Submission date |
Mar 03, 2014 |
| Last update date |
Mar 01, 2015 |
| Contact name |
Christer Larsson |
| E-mail(s) |
christer.larsson@med.lu.se
|
| Organization name |
Lund university
|
| Department |
Laboratory Medicine
|
| Lab |
Translational Cancer Research
|
| Street address |
Medicon Village, Bldg 404:C3
|
| City |
Lund |
| ZIP/Postal code |
223 81 |
| Country |
Sweden |
| |
|
| Platform ID |
GPL10558 |
| Series (1) |
| GSE55503 |
Effects of siRNA targeting PRKCD in breast cancer cells |
|
